Literature DB >> 23256118

High prevalence of primary antibiotic resistance in Helicobacter pylori isolates in Italy.

Ilaria M Saracino1, Angelo Zullo, John Holton, Valentina Castelli, Giulia Fiorini, Cristina Zaccaro, Lorenzo Ridola, Chiara Ricci, Luigi Gatta, Dino Vaira.   

Abstract

BACKGROUND AND AIMS: H. pylori eradication with standard therapies is decreasing worldwide, mainly because of increased primary antibiotic resistance rates. We aimed to assess primary resistance in H. pylori isolates towards the most used antibiotics in clinical practice.
METHODS: The study enrolled consecutive, dyspeptic, adult patients, never treated for H. pylori, who had underwent upper endoscopy. Gastric biopsies were taken for standard histology, and two further antral biopsies were used for H. pylori culture. Minimal inhibitory concentrations (MIC) >/= 1, >/= 8 and >/= 1 mg/L were used as break point for clarithromycin, metronidazole, and levofloxacin resistance, respectively.
RESULTS: Bacterial culture was successful in 145 (94%) out of 154 infected patients. Resistance towards at least one antibiotic was detected in 111 (76.6%) isolated, and multiple antibiotic resistance in 35.2% of cases. Primary resistance towards clarithromycin, metronidazole, and levofloxacin was detected in 51 (35.2%), 86 (59.3%), and in 32 isolated (22.1%), respectively. Levofloxacin resistance was significantly associated with the male sex (OR: 11.3, 95% CI = 1.2-103; P = 0.03), whilst females were at a higher risk of being infected with bacterial strains harbouring a double clarithromycin and metronidazole resistance (OR: 4.9, 95% CI = 1.2-19.8, P = 0.02).
CONCLUSION: Our data indicate a very high primary resistance rate towards the most used antibiotics in H. pylori isolates. The efficacy of standard eradication therapies is expected to further decrease in the next years.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23256118

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN: 1841-8724            Impact factor:   2.008


  18 in total

1.  Low efficacy of levofloxacin-doxycycline-based third-line triple therapy for Helicobacter pylori eradication in Italy.

Authors:  Omero Alessandro Paoluzi; Giovanna Del Vecchio Blanco; Emanuela Visconti; Manuela Coppola; Carla Fontana; Marco Favaro; Francesco Pallone
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

Review 2.  How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?

Authors:  Enzo Ierardi; Floriana Giorgio; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastroenterol       Date:  2013-12-07       Impact factor: 5.742

Review 3.  Prevalence of antibiotic resistance in Helicobacter pylori: A recent literature review.

Authors:  Reza Ghotaslou; Hamed Ebrahimzadeh Leylabadlo; Yalda Mohammadzadeh Asl
Journal:  World J Methodol       Date:  2015-09-26

4.  Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori.

Authors:  Raj Gopal; Thirthar Palanivelu Elamurugan; Vikram Kate; Sadasivan Jagdish; Debdatta Basu
Journal:  World J Gastrointest Pharmacol Ther       Date:  2013-05-06

Review 5.  Are probiotics useful in Helicobacter pylori eradication?

Authors:  Matjaž Homan; Rok Orel
Journal:  World J Gastroenterol       Date:  2015-10-07       Impact factor: 5.742

6.  Primary Antimicrobial Susceptibility Changes in Children with Helicobacter pylori Infection over 13 Years in Northern Italy.

Authors:  Marco Manfredi; Pierpacifico Gismondi; Valentina Maffini; Barbara Bizzarri; Fabiola Fornaroli; Carmen Madia; Antonino Salerno; A Marta Cangelosi; Gian Luigi de'Angelis
Journal:  Gastroenterol Res Pract       Date:  2015-05-06       Impact factor: 2.260

Review 7.  Review article: the global emergence of Helicobacter pylori antibiotic resistance.

Authors:  I Thung; H Aramin; V Vavinskaya; S Gupta; J Y Park; S E Crowe; M A Valasek
Journal:  Aliment Pharmacol Ther       Date:  2015-12-23       Impact factor: 8.171

8.  Online Registry for Nationwide Database of Current Trend of Helicobacter pylori Eradication in Korea: Interim Analysis.

Authors:  Beom Jin Kim; Hyun-Soo Kim; Hyun Joo Song; Il-Kwun Chung; Gwang Ha Kim; Byung-Wook Kim; Ki-Nam Shim; Seong Woo Jeon; Yun Jin Jung; Chang-Hun Yang; Ji Hyun Kim; Tae Ho Kim; Sang Gyun Kim; Woon Geon Shin; Sun Moon Kim; Sok Won Han; Jun Haeng Lee; Kyung Ho Kim; Sue K Park; Byung-Joo Park; Joongyub Lee; Jae G Kim
Journal:  J Korean Med Sci       Date:  2016-05-16       Impact factor: 2.153

9.  Pilot study: Comparing efficacy of 14-day triple therapy Clarithromycin versus levofloxacin on eradication of Helicobacter pylori infection in Syrian population single-center experience.

Authors:  Khaled Mohammad Cheha; Sawsan Omar Ali Dib; Marouf Mohammad Alhalabi
Journal:  Avicenna J Med       Date:  2018 Jan-Mar

10.  A Comparison between Hybrid and Concomitant Regimens for Helicobacter Pylori Eradication: A Randomized Clinical Trial.

Authors:  Saman Alhooei; Hafez Tirgar Fakheri; Vahid Hosseini; Iradj Maleki; Tarang Taghvaei; Seyed Mohammad Valizadeh; Zohreh Bari
Journal:  Middle East J Dig Dis       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.